ExamWorks Group, a rollup of independent medical exam providers that confirms insurance claims, raised $165 million on Wednesday by offering 10.3 million shares at the low end of its $16 to $18 proposed range. ExamWorks Group will begin trading Thursday on the NYSE under the symbol EXAM. Goldman, Sachs & Co., Credit Suisse, and Barclays Capital acted as lead managers on the deal.
